Summarized by Masters of Longevity from Longevity Technology.
A news article about a randomized, blinded dog trial of a gene therapy; it previews scientific results and upcoming conference presentation.
Key Takeaways
- The SLAB trial enrolled 24 beagle dogs older than 10 years and used randomized, blinded allocation.
- The primary endpoint was reduced biological age as measured by the GRIM methylation clock and was met.
- Genflow plans to present detailed mechanistic and methylation results at the Animal Longevity Summit in October 2026.
